Keyphrases
Liposomal
86%
Methylseleninic Acid
76%
Selenium
61%
Prostate Cancer
53%
Methionine
51%
Methionine Restriction
51%
Tuberculosis
51%
Effective Treatment
51%
Liposome-encapsulated
51%
Mammalian Target of Rapamycin (mTOR)
51%
Prostate Cancer Cells
41%
REDD+
35%
Differentially Expressed Proteins
34%
Therapeutic Efficacy
30%
Healthy Adults
30%
Hypoxia-inducible factor-1α (HIF-1α)
29%
Serum Samples
28%
Rat Prostate
28%
Immune Function
28%
Hypoxia
28%
Lung
26%
Glutathione
25%
Total Sulfur Amino Acids
25%
Breast Cancer
25%
Celecoxib
25%
Prostate Carcinoma
25%
Body Shop
25%
Cancer Cell Growth
25%
Oral nutritional Supplements
25%
Selenium Yeast
25%
Electronic Cigarettes
25%
Prognostic Performance
25%
Selenium Supplementation
25%
Cytokine Storm
25%
Serological Characteristics
25%
Sulfur Amino Acid Restriction
25%
Lupus
25%
MetR
25%
Saliva Samples
25%
Cytotoxicity
25%
Antitumor Properties
25%
Early Markers
25%
Esophageal Squamous Cell Carcinoma
25%
Dysregulation
25%
Lung Proteome
25%
Apolipoprotein A-I (ApoA-I)
25%
Diagnostic Performance
25%
Adenocarcinoma Cells
25%
Mammalian Target of Rapamycin Signaling
25%
Cervical Cells
25%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Biological Marker
53%
Clofazimine
51%
Methionine
51%
Neoplasm
41%
Nicotine-Derived Nitrosamine Ketone
39%
Selenium Compound
34%
4 (Methylnitrosamino) 1 (3 Pyridyl) 1 Butanone
28%
Carcinogen
28%
Cancer Growth
27%
Adenocarcinoma
25%
Inflammation
25%
Prostatic Intraepithelial Neoplasia
25%
Human Papillomavirus
25%
Cytokine Storm
25%
2 Butanone
25%
Liposome
25%
Clusterin
25%
Celecoxib
25%
Glutathione
25%
Corn Oil
25%
Murine
25%
Esophageal Squamous Cell Carcinoma
25%
Carbene
25%
Nude Mouse
25%
Electronic Cigarette
25%
Mycobacterium Avium Complex
25%
Fish Oil
25%
Mammalian Target of Rapamycin
25%
Rapamycin
25%
Hypoxia
25%
Diseases
19%
Malignant Neoplasm
18%
Western Blot
18%
Placebo
17%
Chemopreventive Agents
17%
Tumor Necrosis Factor
17%
Interleukin 6
17%
Androgen
12%
Transcription Factor Nrf2
12%
Carcinogenesis
10%
Complement
8%
Isocitrate Dehydrogenase
8%
Prostate Specific Antigen
8%
Trypsin Inhibitor
8%
Disease Exacerbation
8%
Antioxidant
8%
Pyrazole
8%
Plasma Protein
8%
Medicine and Dentistry
Methionine
76%
Prostate Cancer
61%
Cancer Cell
42%
Diet Restriction
35%
Oxidative Stress
34%
Cytotoxicity
31%
Immune Function
27%
Sulfur Amino Acid
27%
Cancer Growth
27%
Breast Cancer
27%
Mechanistic Target of Rapamycin
25%
Cell Cycle
25%
Hypoxia
25%
Electronic Cigarette
25%
Adenocarcinoma
25%
Carbene
25%
In Vitro
25%
Supplementation
25%
Neoplasm
25%
Rapamycin
25%
Proteomics
25%
Breast Disease
25%
Mammalian Target of Rapamycin
25%
Prostatic Intraepithelial Neoplasia
25%
Glutathione
25%
Serositis
25%
Diseases
22%
Biological Marker
19%
Cysteine
18%
Epithelial Cell
12%
Erythrocyte
12%
Androgen
12%
Peripheral Blood Mononuclear Cell
12%
Malignant Neoplasm
12%
8 Isoprostane
11%
Uric Acid
10%
FGF21
10%
Blood Urea Nitrogen
10%
Body Weight
9%
Neutrophil Response
8%
Interaction Network
8%
Random Effects Model
8%
Exocytosis
8%
Cytokine
8%
Cancer Diagnosis
8%
Cancer Prognosis
8%
Phagocytosis
8%
Early Intervention
8%
Macrophage
8%
Breast Cancer Screening
8%
